Assessing the value of a cancer clinical nurse specialist
Clinical Previous     Next

Assessing the value of a cancer clinical nurse specialist

Anne Sullivan Associate director of nursing/Macmillan lead cancer nurse, Worcestershire Acute Hospitals NHS Trust, Worcester
Simon Elliott Macmillan senior development manager, Macmillan Cancer Support, Coventry

NHS organisations are going through challenging financial times, in line with government-directed financial and structural reforms. It is acknowledged that cost cutting measures help balance the books in the short term, but there is a danger here that the role of the cancer clinical nurse specialist (CNS) could be seen as a luxury. Any plans to reduce numbers of specialist cancer nurses would, many believe, undermine the key government policy objectives of delivering the NHS Modernisation Agenda. This paper describes how the cancer CNS can help deliver quality clinical care within tight financial limits. It is based on a focus group held with Macmillan Cancer Support CNSs discussing their impact on the delivery of the Modernisation Agency’s 10 High Impact Changes.

Cancer Nursing Practice. 6, 10,25-28. doi: 10.7748/cnp2007.12.6.10.25.c6319

You need a subscription to read the full article